Append KD modifier for DME pump drugs

Why This Topic Matters

The article helps coders, billers, and reimbursement staff recognize when pump-related drug claims need additional documentation and modifier reporting so claims are not submitted inconsistently. It is relevant to practices handling Medicare claims for infusion pump refills and compounded medications.

Article Sections

1. KD modifier use for DME pump drugs

   Introduces the topic of billing drugs or biologics administered through durable medical equipment infusion pumps and the related modifier reporting focus. It also notes documentation and claim submission considerations.

2. Medicare contractor guidance and billing concerns

   Summarizes contractor commentary on claim patterns and refers readers to Medicare bulletin materials and a CMS transmittal. It places the guidance in the context of billing compliance for pump refill claims.

3. Coding guidelines for compounded pump medications

   Describes related local coverage guidance for pump infusion drugs, including references to an LCD, invoice documentation, and pharmacy information requirements. It also addresses compounded medications used for pump refills.